...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>e-Jurnal Medika Udayana >DIAGNOSTIC AND INDICATION OF BLOOD TRANSFUSION IN APLASTIC ANEMIA
【24h】

DIAGNOSTIC AND INDICATION OF BLOOD TRANSFUSION IN APLASTIC ANEMIA

机译：再生障碍性贫血的输血诊断与指征

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Aplastic anemia is a disease caused by a failure of the bone marrow to produce blood cells components resulting anemia with pancytopenia. symptoms will arise according to the blood cells decreased. Aplastic anemia is a rare and severe disease. The International Aplastic anemia and agranulocytosis Study found the incidence of aplastic anemia in Europe about 2 than 1,000,000 per year. Incidents in Asia 2 to 3 times higher than in Europe. In China, the incidence is estimated to 7 cases per 1,000,000 people and in Thailand is estimated to 4 cases per 1,000,000 people. The highest frequency at 15 and 25 years, the second highest peak at age 65 and 69 years. The cause of aplastic anemia majority (50-70%) is unknown. Enforcement of diagnosis based on history, physical examination, laboratory investigations and radiological either. One treatment in aplastic anemia is a blood transfusion. Blood transfusion in aplastic anemia is necessary when haemoglobin levels <7 g / dl and platelet count <20.000/?L.
机译：再生障碍性贫血是由骨髓不能产生血细胞成分引起的疾病，导致贫血与全血细胞减少症。症状会根据血细胞减少而出现。再生障碍性贫血是一种罕见且严重的疾病。国际再生障碍性贫血和粒细胞缺乏症研究发现，欧洲再生障碍性贫血的发病率每年约为2到1,000,000。亚洲的事故率是欧洲的2至3倍。在中国，发病率估计为每100万人中有7例，而在泰国，估计为每100万人中有4例。在15和25岁时出现频率最高，在65和69岁时出现第二高峰。再生障碍性贫血的主要原因（50-70％）尚不清楚。根据病史，体格检查，实验室检查和放射学进行诊断。再生障碍性贫血的一种治疗方法是输血。当血红蛋白水平<7 g / dl和血小板计数<20.000 /？L时，必须在再生障碍性贫血中输血。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号